Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
Objective To review and appraise the validity and usefulness of published and preprint
reports of prediction models for prognosis of patients with covid-19, and for detecting people …
reports of prediction models for prognosis of patients with covid-19, and for detecting people …
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta …
Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …
19. We compared the effects of the preadmission use of antidiabetic medications on the in …
Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: the prospective …
C Sourij, NJ Tripolt, F Aziz, F Aberer… - Diabetes, Obesity …, 2022 - Wiley Online Library
Aims To investigate the seroconversion following first and second COVID‐19 vaccination in
people with type 1 and type 2 diabetes in relation to glycaemic control prior to vaccination …
people with type 1 and type 2 diabetes in relation to glycaemic control prior to vaccination …
Mortality risk of antidiabetic agents for type 2 diabetes with COVID-19: a systematic review and meta-analysis
C Kan, Y Zhang, F Han, Q Xu, T Ye, N Hou… - Frontiers in …, 2021 - frontiersin.org
Aims We conducted a systematic review and meta-analysis to assess various antidiabetic
agents' association with mortality in patients with type 2 diabetes (T2DM) who have …
agents' association with mortality in patients with type 2 diabetes (T2DM) who have …
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and …
TI Hariyanto, D Intan, JE Hananto, C Putri… - diabetes research and …, 2021 - Elsevier
Aims GLP-1RA has many beneficial properties, including anti-inflammatory, anti-
obesogenic, pulmonary protective effects as well as beneficial impact on gut microbiome …
obesogenic, pulmonary protective effects as well as beneficial impact on gut microbiome …
Association of glucose-lowering drugs with outcomes in patients with diabetes before hospitalization for COVID-19: a systematic review and network meta-analysis
Z Zhu, Q Zeng, Q Liu, J Wen, G Chen - JAMA network open, 2022 - jamanetwork.com
Importance Patients with COVID-19 have a high prevalence of diabetes, and diabetes and
blood glucose control are determinants of intensive care unit admission and mortality …
blood glucose control are determinants of intensive care unit admission and mortality …
[HTML][HTML] A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes
ZA Damanhouri, HM Alkreathy, FA Alharbi… - … Journal of Medical …, 2023 - ncbi.nlm.nih.gov
Metformin is the most often prescribed drug for people with type 2 diabetes (T2D). More than
120 million patients with T2D use metformin worldwide. However, monotherapy fails to …
120 million patients with T2D use metformin worldwide. However, monotherapy fails to …
The association between antidiabetic agents and clinical outcomes of COVID-19 patients with diabetes: a Bayesian network meta-analysis
Y Chen, X Lv, S Lin, M Arshad, M Dai - Frontiers in Endocrinology, 2022 - frontiersin.org
Aims This study aimed to assess the impact of different antidiabetic agents on individuals
with diabetes and COVID-19. Methods We searched PubMed, Web of Science, Embase …
with diabetes and COVID-19. Methods We searched PubMed, Web of Science, Embase …
Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta …
TI Hariyanto, A Kurniawan - Journal of Diabetes & Metabolic Disorders, 2021 - Springer
Background One of the drugs which is commonly used in diabetic patients is Dipeptidyl
Peptidase-4 (DPP-4) inhibitor. Currently, the association between DPP-4 inhibitor and …
Peptidase-4 (DPP-4) inhibitor. Currently, the association between DPP-4 inhibitor and …